Free Trial

PolyPid (PYPD) Competitors

PolyPid logo
$3.74 -0.02 (-0.53%)
Closing price 07/24/2025 04:00 PM Eastern
Extended Trading
$3.76 +0.01 (+0.40%)
As of 07/24/2025 05:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PYPD vs. LAKE, LUCD, INFU, OBIO, AVR, LUNG, ICAD, FONR, ZJYL, and MBOT

Should you be buying PolyPid stock or one of its competitors? The main competitors of PolyPid include Lakeland Industries (LAKE), Lucid Diagnostics (LUCD), InfuSystem (INFU), Orchestra BioMed (OBIO), Anteris Technologies Global (AVR), Pulmonx (LUNG), icad (ICAD), Fonar (FONR), Jin Medical International (ZJYL), and Microbot Medical (MBOT). These companies are all part of the "medical equipment" industry.

PolyPid vs. Its Competitors

Lakeland Industries (NASDAQ:LAKE) and PolyPid (NASDAQ:PYPD) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

PolyPid has a net margin of 0.00% compared to Lakeland Industries' net margin of -13.31%. Lakeland Industries' return on equity of -6.88% beat PolyPid's return on equity.

Company Net Margins Return on Equity Return on Assets
Lakeland Industries-13.31% -6.88% -4.47%
PolyPid N/A -1,069.37%-151.85%

71.7% of Lakeland Industries shares are owned by institutional investors. Comparatively, 26.5% of PolyPid shares are owned by institutional investors. 1.9% of Lakeland Industries shares are owned by insiders. Comparatively, 24.7% of PolyPid shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Lakeland Industries has higher revenue and earnings than PolyPid. Lakeland Industries is trading at a lower price-to-earnings ratio than PolyPid, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lakeland Industries$167.21M0.84-$18.08M-$3.01-4.93
PolyPidN/AN/A-$29.02M-$4.30-0.87

Lakeland Industries has a beta of 1.01, suggesting that its share price is 1% more volatile than the S&P 500. Comparatively, PolyPid has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500.

In the previous week, Lakeland Industries had 5 more articles in the media than PolyPid. MarketBeat recorded 6 mentions for Lakeland Industries and 1 mentions for PolyPid. PolyPid's average media sentiment score of 1.89 beat Lakeland Industries' score of 0.38 indicating that PolyPid is being referred to more favorably in the news media.

Company Overall Sentiment
Lakeland Industries Neutral
PolyPid Very Positive

Lakeland Industries currently has a consensus price target of $26.00, indicating a potential upside of 75.20%. PolyPid has a consensus price target of $11.80, indicating a potential upside of 215.51%. Given PolyPid's stronger consensus rating and higher possible upside, analysts clearly believe PolyPid is more favorable than Lakeland Industries.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lakeland Industries
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
PolyPid
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.17

Summary

PolyPid beats Lakeland Industries on 9 of the 16 factors compared between the two stocks.

Get PolyPid News Delivered to You Automatically

Sign up to receive the latest news and ratings for PYPD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PYPD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PYPD vs. The Competition

MetricPolyPidMED IndustryMedical SectorNASDAQ Exchange
Market Cap$38.32M$2.77B$5.73B$9.48B
Dividend YieldN/A1.78%4.60%3.99%
P/E Ratio-0.879.1227.9319.95
Price / SalesN/A736.29440.29101.76
Price / CashN/A166.2336.5558.97
Price / Book4.995.228.645.90
Net Income-$29.02M$30.99M$3.24B$258.42M
7 Day Performance3.31%4.60%3.73%2.12%
1 Month PerformanceN/A12.70%10.35%12.46%
1 Year Performance6.86%-0.48%34.25%19.56%

PolyPid Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PYPD
PolyPid
2.3841 of 5 stars
$3.74
-0.5%
$11.80
+215.5%
+7.2%$38.32MN/A-0.8780
LAKE
Lakeland Industries
4.7504 of 5 stars
$13.78
-3.7%
$26.00
+88.7%
-36.6%$131.12M$177.65M-4.582,100High Trading Volume
LUCD
Lucid Diagnostics
2.8361 of 5 stars
$1.17
+2.6%
$3.55
+203.4%
+29.4%$126.58M$4.17M-0.8770Positive News
INFU
InfuSystem
3.3205 of 5 stars
$5.61
-3.3%
$13.00
+131.7%
N/A$117.90M$137.58M93.52410News Coverage
Analyst Forecast
Analyst Revision
OBIO
Orchestra BioMed
2.403 of 5 stars
$3.03
+3.8%
$14.20
+368.6%
-59.8%$116.08M$2.64M-1.704News Coverage
Positive News
AVR
Anteris Technologies Global
N/A$3.07
-3.5%
$16.50
+437.5%
N/A$110.71M$2.49M0.00138
LUNG
Pulmonx
3.1333 of 5 stars
$2.68
-7.6%
$11.53
+330.0%
-60.0%$107.90M$83.79M-1.86250Upcoming Earnings
Gap Up
ICAD
icad
1.0881 of 5 stars
$3.82
+2.1%
N/AN/A$104.94M$19.53M-20.11140
FONR
Fonar
1.3486 of 5 stars
$16.31
+2.9%
N/A-14.0%$101.17M$103.02M13.05480High Trading Volume
ZJYL
Jin Medical International
N/A$0.60
-6.0%
N/A-80.2%$94.21M$23.50M0.00245Positive News
Gap Up
MBOT
Microbot Medical
2.1223 of 5 stars
$2.52
-3.8%
$9.00
+257.1%
+168.6%$91.67MN/A-3.8820Gap Up

Related Companies and Tools


This page (NASDAQ:PYPD) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners